Rx-to-OTC switch meeting
This article was originally published in The Tan Sheet
Executive Summary
Consumer Healthcare Products Association planning July 29 meeting with FDA and industry representatives on OTC switches. The session is not intended to focus on a specific product category. However, ways around FDA's current position that hypercholesterolemia drugs are not appropriate switches is a likely topic for discussion